SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CoCensys
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
190 3 0 COCN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
115 The epilepsy data are impossible to interpret. They say: "subjects in theDr. John M. de Castro-11/7/1997
114 Thanks NI, have to agree that the migraine statements are not too clear. ButAndrew H-11/7/1997
113 The use of the word 'overall' is a bit ambiguous, but I would surmise NeuroInvestment-11/6/1997
112 NI--would appreciate your reaction to the release, especially the paragraph belAndrew H-11/6/1997
111 Thursday November 6 9:57 PM EST Company Press Release Ganaxolone Shows EncouAndrew H-11/6/1997
110 Ganaxolone Shows Encouraging Clinical Results in Phase II Epilepsy and MigraineThomas Kirwin-11/6/1997
109 >>one would herald failures more quietly, they are trying to maximize theAndrew H-11/6/1997
108 It is clear that my timeframe was off, and the way this is being presented certNeuroInvestment-11/6/1997
107 Thanks for the update, John. From the tape action today, looks like the news wiAndrew H-11/6/1997
106 There will be a press release tommorrow on the epilepsy trial results. Very hJohn Erb-11/6/1997
105 Likewise, it's nice to get a quick response, and also be able to decipher tJames Ratzliff-11/5/1997
104 Hi NI. Its like magic, mention your name and you post! Thanks for the update. AAndrew H-11/5/1997
103 I am not expecting the migraine/epilepsy PhII data to be released this early inNeuroInvestment-11/5/1997
102 I have no info on presentation of the epilepsy trials results. Perhaps NeuroInvAndrew H-11/5/1997
101 I have heard that they were unveiling the clinical trial results (for epilepsy)James Ratzliff-11/5/1997
100 Thnaks for your take, NI. Any read about the migraine results? I expect the eAndrew H-10/9/1997
99 The market undoubtedly was hoping that clinical data for ganaxolone would be prNeuroInvestment-10/9/1997
98 Looks like the market doesn't think much of the announcement.Andrew H-10/9/1997
97 News....Thursday October 9 6:30 AM EDT Company Press Release Watson PharmaceThomas Kirwin-10/9/1997
96 It touched 6 a few days ago, also. Needs to close above 6 and hold for a few daAndrew H-10/8/1997
95 Hit $6.00 Today! Andrew, COCN touched the $6.00 mark today. We could be on oThomas Kirwin-10/8/1997
94 Thomas, nice move today. A close above 6 should portend higher prices.Andrew H-10/7/1997
93 Thanks for the input.I guess we will know in or about Nov.EUGENE A. LLOYD-10/1/1997
92 Looks like NI answered your question.Andrew H-9/30/1997
91 CoCensys sponsored a small Phase II study (10 -15 patients if I recall correctNeuroInvestment-9/30/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News